Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
ORLADEYO Kaps 150 mg 28 Stk
Drug
Orladeyo, Hartkapseln
Hereditäres Angioödem
02.99.0. – various
HAM – Human medicine
KAHA – Capsule, hard
S – synthetic products for human use
B – Dispensed on prescription by a physician or veterinarian (B)
Z – approved
6/7/2022
6/6/2027
Dosage strength
Orladeyo 150 mg, Hartkapseln
Hereditäres Angioödem
01
Z – approved
Package
7680684640018
No information made available
A/R – Authorised / referenced
28
001
Z – approved
Declaration
Component
150 mg berotralstatum
berotralstati dihydrochloridum
berotralstati dihydrochloridum
amylum pregelificatum
crospovidonum
silica colloidalis anhydrica
magnesii stearas
gelatina
E 171
E 132
E 172 (nigrum)
E 172 (rubrum)
lacca
propylenglycolum
kalii hydroxidum
E 172 (nigrum)
crospovidonum
silica colloidalis anhydrica
magnesii stearas
gelatina
E 171
E 132
E 172 (nigrum)
E 172 (rubrum)
lacca
propylenglycolum
kalii hydroxidum
E 172 (nigrum)
Spezialitätenliste***
SL
-
-
13334.55
None
Yes
10%
No
Authorisation holder
7601001552807
BioCryst Schweiz GmbH
6300 ZUG (ZG)
6300 ZUG (ZG)
Date of revision of the text
3/19/2024
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.